A VA analysis of more than 33,000 high-risk patients with prior keratinocyte carcinoma reports oral nicotinamide prevented an estimated 624 skin cancers per year translating to a roughly 20% reduction in annual non-melanoma skin cancer treatment costs. | Perez, JAMA Dermatol 2026
